BioNTech Deal With Senegal, Rwanda to Make mRNA Vaccine in Mid 2022
Summary- BioNTech in bid to build manufacturing expertise in Africa Project seeks to avoid repeat of COVID-19 vaccine inequality Backed by EU…
Summary- BioNTech in bid to build manufacturing expertise in Africa Project seeks to avoid repeat of COVID-19 vaccine inequality Backed by EU…
Keypoints: PTC Therapeutics, Inc. announced that the Brazilian National Health Surveillance Agency has approved the expansion of the indication of Translarna (Ataluren)…
Keypoints Med-X, Inc. announced that the Company received Patent No. 11,147,266 B2 for its Nature-Cide Insecticidal Soil formulation. Med-X’s goal is to…
India is poised to be a $10 trillion economy by 2030. There also exist opportunities to enable and empower industries that have…
Cipla healthcare has launched Naselin antiviral nasal spray with Povidone Iodine that can offer the first line of defence against the COVID-causing…
Glenmark Pharmaceuticals on Tuesday said it has launched a fixed-dose combination drug for the treatment of Type 2 diabetes in the country.…
FDA approved Genentech’s Susvimo, a port delivery system with a customized formulation of Ranibizumab, the active ingredient in Lucentis. Now, the trick for…
The European Commission has cleared Keytruda (Pembrolizumab) in combination with chemotherapy as a first-line treatment for locally recurrent, unresectable or metastatic TNBC…
NPPA fixed the ceiling prices for 12 anti-diabetic generic medicines, including Glimepiride tablets, glucose injection and intermediate acting insulin solution. Drug price…
Bausch Health Companies Inc and Clearside Biomedical Inc said on Monday they received approval from the U.S. health regulator for their…